Net Cash Provided by (Used in) Operating Activities |
-35.8M |
USD |
-267% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
-224M |
USD |
+17.5% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
275M |
USD |
-4.12% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
500M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
140M |
shares |
+0.62% |
Q2 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
15.4M |
USD |
-58.3% |
Q1 2025 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
228M |
USD |
+34.5% |
Q2 2025 |
Q2 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
91.9M |
USD |
-21.2% |
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
60.3M |
USD |
+126% |
Q2 2025 |
Q2 2025 |
Depreciation |
5.5M |
USD |
-42.1% |
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Operating Loss Carryforwards |
23.5M |
USD |
+32% |
Q4 2024 |
FY 2024 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q2 2025 |
Q2 2025 |
Additional Paid in Capital |
2.75B |
USD |
+0.62% |
Q2 2025 |
Q2 2025 |
Interest Expense |
382M |
USD |
-19.3% |
Q2 2025 |
Q2 2025 |